TNNT2 and acute lymphoblastic leukemia: Elevated cTnT levels, as assessed using standard assays, after initial doxorubicin therapy for acute lymphoblastic leukaemia in children has been shown to associate with LV dilation and wall thinning 9 months later [18] and reduced LV mass 4 years later [19].